Spectrawave’s tools are intended to improve PCI treatment and will be integrated into Philips’ Azurion imaging platform.

Transient loss of vision is associated with an increased risk for cardiovascular events within 14 days of diagnosis, and ...

December 15, 2025Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced ...

Palvella Therapeutics reports Phase 2 data showing 73% improvement with QTORIN rapamycin gel in cutaneous venous ...

Rising unemployment, falling job vacancies, and millions have given up looking for work as mental health problems take their ...

Women with fibroids have an 81% higher risk of cardiovascular disease, with Black women disproportionately affected and often dismissed when seeking care.

Philips (NYSE: PHG) announced that it agreed to acquire SpectraWave, a developer of Enhanced Vascular Imaging (EVI) for ...

For almost three decades, functional magnetic resonance imaging (fMRI) has been one of the main tools in brain research. Yet ...

Philips acquires SpectraWave as medtech deals increase in December, with AI-powered coronary imaging technology boosting portfolio.

Philips add heart imaging by acquiring SpectraWave’s AI-powered coronary imaging and physiology technologies to enhance its intravascular portfolio.

A common, non-invasive skin imaging technique can predict which melanoma patients face a higher risk of metastasis as accurately as current methods that require analyzing tumor samples after surgery.

There is increasing evidence that gum disease is associated with increased risk of cardiovascular events, including heart ...